Malignancy, Male Reproductive System with MCC: Inpatient Reimbursement Overview
DRG 722 addresses inpatient stays for malignancy of the male reproductive system with a Major Complication or Comorbidity, covering higher-severity cases that drive increased resource use. It matters for inpatient reimbursement because Medicare Severity Diagnosis-Related Group assignment, influenced by documented comorbidities and complications, affects hospital payment levels under Centers for Medicare & Medicaid Services rules.
Customize your policy alerts
Sign up for drg 722 policy alerts
Get alerted when payer policies referencing 722 are released or updated.
Monitor payer policy activity
DRG 722 Overview
DRG 722 covers hospital admissions for malignant neoplasms of the male reproductive system when a Major Complication or Comorbidity is present, typically including complex cases such as advanced prostate or testicular cancers with significant secondary conditions. This Diagnosis-Related Group groups patients by clinical similarity and resource use, informing Medicare inpatient payment adjustments based on severity. The presence of a Major Complication or Comorbidity increases expected resource consumption and payment relative to less severe groupings. Hospitals and coders use this DRG to align clinical documentation with appropriate Medicare Severity Diagnosis-Related Group reimbursement.